XML 61 R43.htm IDEA: XBRL DOCUMENT v3.25.4
Summary of Significant Accounting Policies - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Numerator:      
Net loss $ (978) $ (128,071) $ (148,173)
Less: Net income (loss) attributable to noncontrolling interests (254) (36) (156)
Net loss attributable to Alignment Healthcare, Inc. $ (724) $ (128,035) $ (148,017)
Denominator:      
Total weighted-average common shares outstanding - basic (in shares) 198,017,704 191,150,693 188,420,487
Total weighted-average common shares outstanding - diluted (in shares) 198,017,704 191,150,693 188,420,487
Less: Restricted shares of common stock (in shares) (11,488) (357,141) (2,205,703)
Total weighted-average common shares outstanding - basic (in shares) 198,006,216 190,793,552 186,214,784
Total weighted-average common shares outstanding, net of restricted shares of common stock - diluted (in shares) 198,006,216 190,793,552 186,214,784
Net loss per share:      
Net loss per share attributable to Alignment Healthcare, Inc. - basic (in dollars per share) $ 0.00 $ (0.67) $ (0.79)
Net loss per share attributable to Alignment Healthcare, Inc. - diluted (in dollars per share) $ 0.00 $ (0.67) $ (0.79)